Overview

• Shares are up more than 600% over the past year through Sept. 16, with a recent lift after regulatory approval to acquire Oxford Ionics.
• IonQ says the Oxford Ionics deal bolsters its technology as Oxford holds a world-record fidelity and could help address error-prone devices.
• A Sept. 12 analyst day prompted Wall Street upgrades that added momentum to the stock.
• YCharts data show the price-to-sales multiple is now higher than it has been over the last couple of years.
• The stock’s beta was above 2.5 as of Sept. 16, and the article recommends waiting before buying, noting Stock Advisor did not include IonQ among its top picks.